0001209191-16-148045.txt : 20161102 0001209191-16-148045.hdr.sgml : 20161102 20161102203907 ACCESSION NUMBER: 0001209191-16-148045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161031 FILED AS OF DATE: 20161102 DATE AS OF CHANGE: 20161102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SIGNAL GENETICS, INC. CENTRAL INDEX KEY: 0001590750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 471187261 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5740 FLEET STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (760) 537-4100 MAIL ADDRESS: STREET 1: 5740 FLEET STREET CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: SIGNAL GENETICS LLC DATE OF NAME CHANGE: 20131031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEYMOUR TAMARA A CENTRAL INDEX KEY: 0001288232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36483 FILM NUMBER: 161969645 MAIL ADDRESS: STREET 1: C/O SIGNAL GENETICS, INC. STREET 2: 5740 FLEET STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-10-31 0 0001590750 SIGNAL GENETICS, INC. SGNL 0001288232 SEYMOUR TAMARA A C/O SIGNAL GENETICS, INC. 5740 FLEET STREET CARLSBAD CA 92008 0 1 0 0 CFO, Secretary, Treasurer Common Stock 2016-10-31 4 M 0 46000 A 72994 I By Trust Common Stock 2016-10-31 4 F 0 20967 0.36 D 52027 I By Trust Common Stock 2016-10-31 4 M 0 100000 A 152027 I By Trust Common Stock 2016-10-31 4 F 0 45580 0.36 D 106447 I By Trust Restricted Stock Units 2016-10-31 4 M 0 46000 0.00 D Common Stock 46000 0 D Restricted Stock Units 2016-10-31 4 M 0 100000 0.00 D Common Stock 100000 0 D Restricted stock units converted into common stock on a one-for-one basis. Shares withheld to satisfy tax withholding obligations. On August 4, 2014, the reporting person was granted 92,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the "Issuer"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the "Merger Agreement"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of the remaining 46,000 restricted stock units in full. On March 28, 2016, the reporting person was granted 100,000 restricted stock units. In connection with the execution of the Merger Agreement, the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full. /s/Samuel D. Riccitelli, as Attorney-in-Fact for Tamara A. Seymour 2016-11-02